Since our transcriptomic comparisons consistently showed enrichment of the IL6/JAK/STAT3 pathway in SMARCB1-deficient BLCA tumors, we further verified the transcript levels of IL6, JAK1, and STAT3 by qRT-PCR from orthotopic tumors. This evidence concerns the gene STAT3 and bladder transitional cell carcinoma.